Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Merle C. Hoenig"'
Autor:
Verena Dzialas, Merle C. Hoenig, Stéphane Prange, Gérard N. Bischof, the Parkinson’s Progression Marker Initiative, Alexander Drzezga, Thilo van Eimeren
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Resilience in neuroscience generally refers to an individual’s capacity to counteract the adverse effects of a neuropathological condition. While resilience mechanisms in Alzheimer’s disease are well-investigated, knowledge regarding its
Externí odkaz:
https://doaj.org/article/6670e329cb2c466388f32386778e75eb
Autor:
Hendrik Theis, Stéphane Prange, Gérard N. Bischof, Merle C. Hoenig, Marc Tittgemeyer, Lars Timmermann, Gereon R. Fink, Alexander Drzezga, Carsten Eggers, Thilo van Eimeren
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Impulsive-compulsive behaviour (ICB) is a frequently observed non-motor symptom in early Parkinson’s disease after initiating dopamine replacement therapy. At the opposite end of the motivated behaviour spectrum, apathy occurs in early Par
Externí odkaz:
https://doaj.org/article/d8b9f2365bfd433eb5435de244ce6a9f
Publikováno v:
Movement disorders 38(1), 16-20 (2023). doi:10.1002/mds.29266
Across neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease (AD), a disparity between the clinical expression and the extent of pathophysiological burden has been observed. This has fueled the establishment of resilien
Autor:
Merle C. Hoenig, Alexander Drzezga
Publikováno v:
Journal of neurochemistry 164(3), 325-345 (2023). doi:10.1111/jnc.15598
With the advances in modern medicine and the adaptation towards healthier lifestyles, the average life expectancy has doubled since the 1930s, with individuals born in the millennium years now carrying an estimated life expectancy of around 100 years
Autor:
James B. Rowe, Merle C Hoenig, Ece Kocagoncu, Michael Ewers, Minc faculty, Nicolai Franzmeier, Julia Neitzel, Michel J. Grothe, Alexander Drzezga, Antonio P. Strafella, Thilo van Eimeren, Gérard N. Bischof
Publikováno v:
Eur J Nucl Med Mol Imaging
European journal of nuclear medicine and molecular imaging 46(13), 2819-2830 (2019). doi:10.1007/s00259-019-04394-5
European journal of nuclear medicine and molecular imaging 46(13), 2819-2830 (2019). doi:10.1007/s00259-019-04394-5
Our understanding on human neurodegenerative disease was previously limited to clinical data and inferences about the underlying pathology based on histopathological examination. Animal models and in vitro experiments have provided evidence for a cel
Autor:
Marc Tittgemeyer, Carsten Eggers, Hendrik Theis, Lars Timmermann, Gereon R. Fink, Merle C Hoenig, Kathrin Giehl, Jochen Hammes, Thilo van Eimeren, Andrea Greuel, Alexander Drzezga
Publikováno v:
Brain 142(3), 733-743 (2019). doi:10.1093/brain/awz007
Impulsive-compulsive behaviours like pathological gambling or hypersexuality are a frequent side effect of dopamine replacement therapy in patients with Parkinson's disease. Multiple imaging studies suggest a significant reduction of presynaptic dopa
Autor:
Thilo van Eimeren, Gérard N. Bischof, Masoud Tahmasian, Joseph Seemiller, Merle C Hoenig, Alexander Drzezga
Publikováno v:
European journal of nuclear medicine and molecular imaging 48(7), 2272-2282 (2021). doi:10.1007/s00259-020-05183-1
Eur J Nucl Med Mol Imaging
Eur J Nucl Med Mol Imaging
Purpose: Tau pathology progression in Alzheimer's disease (AD) is explained through the network degeneration hypothesis and the neuropathological Braak stages; however, the compatibility of these models remains unclear.Methods: We utilized [18F]AV-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9464bb40042b6902783af77e8a592a32
Autor:
Gereon R. Fink, Merle C Hoenig, Gérard N. Bischof, Alzheimer’s Disease Neuroimaging Initiative, Juraj Kukolja, Thilo van Eimeren, Klaus Fliessbach, Elke Kalbe, Özgür A. Onur, Alexander Drzezga, Bernd Neumaier, Frank Jessen
Publikováno v:
European journal of nuclear medicine and molecular imaging 46(9), 1787-1795 (2019). doi:10.1007/s00259-019-04342-3
European journal of nuclear medicine and molecular imaging 46(9), 1787–1795 (2019). doi:10.1007/s00259-019-04342-3
European journal of nuclear medicine and molecular imaging 46(9), 1787–1795 (2019). doi:10.1007/s00259-019-04342-3
PurposeUsing PET imaging in a group of patients with Alzheimer’s disease (AD), we investigated whether level of education, a proxy for resilience, mitigates the harmful impact of tau pathology on neuronal function.MethodsWe included 38 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1b1e95f4414c734f90bcfe921259835
https://pub.dzne.de/record/140809
https://pub.dzne.de/record/140809
Autor:
Merle C Hoenig, Niclas Willscheid, Gérard N. Bischof, Alexander Drzezga, Thilo van Eimeren, Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
JAMA network open 3(12), e2028337 (2020). doi:10.1001/jamanetworkopen.2020.28337
JAMA Network Open
JAMA network open 3(12), e2028337-(2020). doi:10.1001/jamanetworkopen.2020.28337
JAMA Network Open
JAMA network open 3(12), e2028337-(2020). doi:10.1001/jamanetworkopen.2020.28337
This cross-sectional study examines positron emission tomography (PET) imaging to investigate the burden of tau tangles and amyloid β plaques in super agers, normal agers, and patients with mild cognitive impairment vs younger amyloid-negative contr
Autor:
Alexander Drzezga, Laurent Guillon, Pierre Payoux, J Hammes, Gérard Bischof, T van Eimeren, Merle C Hoenig, B. Neumaie
Publikováno v:
Médecine Nucléaire. 44:87
Introduction La paralysie supranucleaire progressive (PSP) est une maladie neurodegenerative rare, avec une accumulation d’isoforme de la proteine tau a quatre motifs repetes (4R). Cette tauopathie est caracterisee par un syndrome parkinsonien atyp